drugset / Trial / NCT01178931

Dydrogesterone Versus Intravaginal Progesterone in the Luteal Phase Support

NCT01178931

Completed 853 enrolled University of Zagreb
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare efficacy and tolerability of the dydrogesterone and the vaginal progesterone, used for luteal phase support. (Initial start date was January 2009 but not for patients' recruitment only for paper work, documents, team organization, statistical pre-work actions and to gain the official approval of Institutional Review Board. The recruitment started in October 2010 and continued until October 2013.)

Timeline

Start
2010-10
Primary completion
2013-10
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dydrogesterone Other / unclassified 10 mg Oral
Comparator Progesterone Other / unclassified 90 mg Other

Indications

No indication recorded.